Navigation Links
Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research
Date:4/21/2009

_new">www.aacr.org. A copy of the posters presented at AACR may be obtained by contacting the Company.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. We are developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, or ESRD. We are also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 2 clinical development for multiple tumor types. The Company is also engaged in business development activities that include evaluating compounds and companies for in-licensing or acquisition, as well as seeking strategic relationships for our product candidates and for our company. Keryx is headquartered in New York City.

Cautionary Statement

Some of the statements included in this press release, particularly those anticipating future clinical and business prospects for KRX-0401, may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
2. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
3. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals Announces Additions to Management Team
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 Look inside ... hard-working items for the lab, from fluid handling to ... (GIS)—ready to ship when you order. , Preferred ... Pumps , from the L/S® model for precise flow ...
(Date:1/15/2014)... Jan. 15, 2014 ­ RedBrick Health , a ... technology, today announces that EmblemHealth , the ... company, is now providing the RedBrick Compass health assessment, ... to all of its members. EmblemHealth is among the ...
(Date:1/15/2014)... More than 5 million Americans are currently living ... will die with Alzheimer’s or another dementia, according to ... many Americans into looking for ways to improve their ... cognitive disorders. Jonathan Weisman, president of Biohack Pure, is ...
(Date:1/15/2014)... January 15, 2014 DTS Language Services, ... Online Web Portal for Life Science organizations who need document ... the subject matter of their documents in advance with a ... reduce time-to-delivery of translations, often a critical factor in clinical ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2DTS Improves Efficiency for Life Science Document Translations 2
... - Nerites Corp ., a Madison biotechnology company, has ... of funding, bringing the total raised to $3 million in ... clinical trials to verify the efficacy of two products: adhesives ... such as blood, and medical device coatings that block bacterial ...
... Madison, Wis. - Wisconsin's information technology and ... recruiting the talent to leverage IT has become ... and a decline in IT enrollment could leave ... and technical college systems graduate fewer qualified workers ...
... blessed with majestic mountains, fertile valleys, sulfurous lava fields, and ... a day-and-a-half on airplanes (thank God I was able to ... in another world. This is definitely not Kansas Frodo; in ... New Zealand. After dashing through customs, I am back on ...
Cached Biology Technology:IT worker shortage linked to tech enrollment drop 2IT worker shortage linked to tech enrollment drop 3IT worker shortage linked to tech enrollment drop 4IT worker shortage linked to tech enrollment drop 5An upside down view of the future 2An upside down view of the future 3An upside down view of the future 4An upside down view of the future 5
(Date:4/23/2014)... is available in French and Spanish ... 23 April 2014Today, the CEC released its Conservation Assessment ... Approach to Conservation, which identifies 29 priority conservation areas ... includes 11 different protected areas in the states of ... diverse arid and semi-arid habitats inhabited by rare and ...
(Date:4/23/2014)... 2014) People who have had a stroke, often ... function. However, a study conducted in Taiwan, that will ... Transplantation , but is currently freely available on-line as ... found that when one group of stroke victims had ... into the brain and a similar group did not, ...
(Date:4/23/2014)... At a signing ceremony in Buenos Aires yesterday, ... as an associate member state. The move strengthens ... life science communities. It grants Argentinian scientists access ... mutually beneficial collaborations. , "Ever since its inception, ... internationalisation have been at the core of EMBL,s ...
Breaking Biology News(10 mins):Conservation priorities released for several protected areas along US-Mexico border 2Conservation priorities released for several protected areas along US-Mexico border 3Autologous stem cell therapy improves motor function in chronic stroke victims 2
... For several years, many have been quick to attribute ... increases in childhood obesity. Now researchers at the University ... consumption is simply a byproduct of a much bigger ... homes. The study, led by Barry Popkin, W.R. ...
... in 2011 and 2012 made two unexpected discoveries that could ... and aid in the creation of a plan to protect ... along a transect that stretched from the open ocean, across ... bays and inlets around the Rock Islands of Palau, in ...
... Early explorers of Amazonian plants and animals included renowned naturalists ... Wallace. Despite this long history of exploration, new studies are ... species. The key of these discoveries lies in the use ... published in the open access journal ZooKeys ...
Cached Biology News:Fast food not the major cause of rising childhood obesity rates 2Coral reefs in Palau surprisingly resistant to naturally acidified waters 2Coral reefs in Palau surprisingly resistant to naturally acidified waters 3Coral reefs in Palau surprisingly resistant to naturally acidified waters 4Genes and calls reveal 5-fold greater diversity of Amazon frog species 2
Rabbit polyclonal to Presenilin 1, prediluted ( Abpromise for all tested applications). entrezGeneID: 5663 SwissProtID: P49768...
Mouse monoclonal [LPL4A.1] to Plastin L ( Abpromise for all tested applications). SwissProtID: P13796...
... designed for use with the ProQuest Two-Hybrid ... contains deletions in the endogenous GAL4 and ... systems. The strain also has leu2 and ... and prey vectors. MaV203 contains three GAL4 ...
Request Info...
Biology Products: